@article{1b88f4cdf32a49bda3458d0b958af9d1,
title = "MMP9 and CCL18 associate with chronic urticaria while type I, IV, and VI collagens change with omalizumab treatment",
keywords = "Humans, Omalizumab/therapeutic use, Chronic Urticaria/drug therapy, Matrix Metalloproteinase 9/metabolism, Anti-Allergic Agents/therapeutic use, Chemokines, CC/metabolism, Collagen/metabolism, Female, Male, Treatment Outcome",
author = "Bartko, \{Ewa A\} and Maiken Mellergaard and Groen, \{Solveig S\} and Nielsen, \{Signe Holm\} and Jesper Elberling and Aase Handberg and Poulsen, \{Lars K\} and Blom, \{Lars H\} and Jensen, \{Bettina M\}",
year = "2024",
month = sep,
doi = "10.1111/all.16212",
language = "English",
volume = "79",
pages = "2558--2561",
journal = "Allergy",
issn = "0105-4538",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "9",
}